CYCRIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cycrin, and what generic alternatives are available?
Cycrin is a drug marketed by Esi and is included in three NDAs.
The generic ingredient in CYCRIN is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cycrin
A generic version of CYCRIN was approved as medroxyprogesterone acetate by BARR on August 9th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CYCRIN?
- What are the global sales for CYCRIN?
- What is Average Wholesale Price for CYCRIN?
Summary for CYCRIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 3 |
| Patent Applications: | 4,233 |
| DailyMed Link: | CYCRIN at DailyMed |
Recent Clinical Trials for CYCRIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| NRG Oncology | Early Phase 1 |
| National Cancer Institute (NCI) | Early Phase 1 |
| Women's Health Care Clinic, Torrance, California | Phase 4 |
US Patents and Regulatory Information for CYCRIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esi | CYCRIN | medroxyprogesterone acetate | TABLET;ORAL | 081239-001 | Oct 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Esi | CYCRIN | medroxyprogesterone acetate | TABLET;ORAL | 081240-001 | Oct 30, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Esi | CYCRIN | medroxyprogesterone acetate | TABLET;ORAL | 089386-001 | Sep 9, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
